ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPRO CORPORATION
  3. Financials
  4. Pretax margin (%)

NIPRO CORPORATION (8086)

Market cap
¥296B
P/E ratio
18.8x
Nipro manufactures medical devices, generic pharmaceuticals, and pharma packaging materials, serving healthcare institutions with products like dialysis equipment, syringes, and glass vials.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 20263+77.91%
Mar 31, 20251.7-49.53%
Mar 31, 20243.3+18.12%
Mar 31, 20232.8-49.51%
Mar 31, 20225.6-3.32%
Mar 31, 20215.8+8.97%
Mar 31, 20205.3+0.59%
Mar 31, 20195.3-8.30%
Mar 31, 20185.7-10.92%
Mar 31, 20176.4+61.48%
Mar 31, 20164-34.06%
Mar 31, 20156+52.62%
Mar 31, 20144-33.50%
Mar 31, 20136+5.44%
Mar 31, 20125.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat